BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16924647)

  • 1. Epigenetics and chronic lymphocytic leukemia.
    Yu MK
    Am J Hematol; 2006 Nov; 81(11):864-9. PubMed ID: 16924647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics in chronic lymphocytic leukemia.
    Raval A; Byrd JC; Plass C
    Semin Oncol; 2006 Apr; 33(2):157-66. PubMed ID: 16616062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
    Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
    Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential DNA methylation of gene promoters in small B-cell lymphomas.
    Guo J; Burger M; Nimmrich I; Maier S; Becker E; Genc B; Duff D; Rahmatpanah F; Chitma-Matsiga R; Shi H; Berlin K; Huang TH; Caldwell CW
    Am J Clin Pathol; 2005 Sep; 124(3):430-9. PubMed ID: 16191512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes.
    Plass C; Byrd JC; Raval A; Tanner SM; de la Chapelle A
    Br J Haematol; 2007 Dec; 139(5):744-52. PubMed ID: 17961188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG-island methylation and epigenetic control of resistance to chemotherapy.
    Teodoridis JM; Strathdee G; Plumb JA; Brown R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):916-7. PubMed ID: 15506923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F; Brown R
    J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation status of multiple genes in uveal melanoma.
    Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
    Jacinto FV; Ballestar E; Esteller M
    Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation and cancer diagnosis: new methods and applications.
    Dehan P; Kustermans G; Guenin S; Horion J; Boniver J; Delvenne P
    Expert Rev Mol Diagn; 2009 Oct; 9(7):651-7. PubMed ID: 19817550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epigenetics and cancer].
    Kern I; Rossier MF; Chappuis PO
    Rev Med Suisse; 2007 Feb; 3(100):540-2, 544-5. PubMed ID: 17410941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.